Boston Scientific Corporation (NYSE: BSX) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 in San Francisco, California.
|
MARLBOROUGH, Mass., Jan. 3, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 in San Francisco, California. Mike Mahoney, chairman and chief executive officer, will present at approximately 8:15 a.m. PST / 11:15 a.m. EST. Mahoney will be joined by Dan Brennan, executive vice president and chief financial officer, Kenneth Stein, M.D., senior vice president and chief medical officer, Cardiac Rhythm Management, and Lauren Tengler, vice president, Investor Relations, in a question-and-answer session with the host analyst.
On Wednesday February 1, 2023, Boston Scientific will webcast its conference call discussing financial results and business highlights for the fourth quarter ended December 31, 2022. The call will begin at 8:00 a.m. EST, hosted by Mike Mahoney and Dan Brennan. The company will issue a news release announcing financial results for the fourth quarter on February 1 prior to the conference call. A live webcast and replay for each event will be accessible at investors.bostonscientific.com. The replays will be available beginning approximately one hour following the completion of each event. About Boston Scientific
SOURCE Boston Scientific Corporation |
||||||||||||||||
Company Codes: NYSE:BSX |
View original content to download multimedia:
